Today, with just one stock, our Michael Robinson's going to not only prove the tech-yield naysayers wrong, but he's also going to connect you with a high-tech dividend-paying machine…
Category
Michael Robinson
Three Tech Leaders You Can Count on to Pay Out Hefty Dividends
Tech has become the best sector to find dividends that are the least likely to be cut no matter what happens with the economy.
And today, Michael’s sharing with you three of these great tech dividend payers for your portfolio….
The "5G Revolution" Can't Happen Without This Company
Pentagon watchers like me lit up when, last month, the Department of Defense asked for firms to help with a new approach that would blend military and civilian capabilities for the new, ultra-fast broadband cellular communications system.
This is a very big deal: The Pentagon would allow private companies to build up their 5G capacity using parts of the wireless spectrum hitherto reserved for the military.
That means companies would be allowed to access the system without the need to invest billions bidding for wireless licenses at auction.
The practical effect would be wider, faster adoption of the next-gen network by cars, factories, hospitals, offices – you name it.
And bear in mind, this is happening after the President signed a pair of bills designed to boost and secure 5G networks nationwide.
That new legislation, and the Pentagon's willingness to "open the door" on its corner of the broadband spectrum, are like rocket fuel for this new, high-profit technology.
All that is pointing us at one backend play that's set to double its earnings in less than 2.5 years… Full Story
Take Huge Profits from the Markets' "Digital Moonshot"
I've always said it and always will: The road to wealth is paved with tech.
If you've been with me for a while, you've made some lucrative "stops" along the road; nanotechnology, 3-D printing, pharmaceuticals, genetics – just to name a few.
Right now, the road is heading straight toward the "Cloud" – distributed computing.
As we speak, the Cloud is in the midst of revolutionizing virtually the entire economy. Before long, the Cloud will be a player in all of our lives, changing them for the better.
Right now, the Cloud is transforming the stock market itself, offering us one of the most impressive profit catalysts I've ever seen.
I can't think of a better time to move… Full Story
I can't think of a better time to move...
This Stock Could Double by the End of the COVID-19 Pandemic
In China, Spain, Italy, and across the world, we've seen how quickly and easily medical systems can be swamped by big surges in novel coronavirus cases.
In most places here in the United States, healthcare systems have borne up pretty well, though at times, they've been under punishing pressure.
Officials have had to scramble to keep up with demand for care. Among other things, we've seen hotels in New York City pressed into service as hospitals and dormitories for healthcare providers. In Baltimore, the downtown convention center has become a hospital and testing center. In Bayou Segnette State Park, south of New Orleans, even recreational cabins were used as makeshift isolation wards.
That's just some of the improvisation that's had to take place across virtually the entire country.
Technological and medial improvisation has been a recurring theme in some of our talks about the national COVID-19 response.
So today, I want to tell you about a company working to ease the need for such drastic measures. It's not working on a breakthrough vaccine or therapy, or on a lifesaving machine – though its work, in my view, is every bit as important to the fight.
Rather, this company is working on a more, shall we say, basic, foundational approach. And it has a "secret weapon" that can not only help us beat the disease, but has applications and growth potential far beyond healthcare.
Here's what they're up to… Full Story
The Incredible Technology Saving Critically Ill COVID-19 Patients
One of the starkest lessons of the global novel coronavirus pandemic is the need for medicine to start looking at existing drugs and procedures in a new way.
We've already seen the benefits of such an approach. The discovery that remdesivir and dexamethasone – an antiviral and a steroid – could both help save severely ill COVID-19 patients' lives springs right to mind.
But adapting the old to fight the new isn't just limited to drugs. Existing medical technology ("medtech") is being used in entirely new ways, or in situations that would've been unthinkable just 10 or 12 months ago.
That's why today I want to talk to you about two compelling companies behind a radical, aggressive therapy that can deliver a "one-two punch" for coronavirus patients who might've otherwise died… Full Story
How You Can Profit from the Next Transistor Revolution
In 1959, Bell Labs researchers Dawon Kahng and Mohammed Atalla developed the world's first truly compact semiconductor, the MOSFET transistor. Their transistor wasn't the first, but it was the first that could be miniaturized and mass-produced practically.
And when I say "mass-produced," I really mean it…
Analyst Jim Handy, talking to the Computer History Museum, estimated that some 13 sextillion (13, followed by 21 zeros) transistors have been manufactured since the very first prototype in 1947. By his estimate, that makes the transistor the most numerous manmade item in all of human history by a comfortable margin.
In fact, as of 2018, there are probably more transistors on Earth than there are grains of sand.
Good thing, then, they've been growing smaller by the year.
Back in 1954, colorful Regency TR-1 "pocket" radios sold for the equivalent of $476 in today's dollars. The TR-1's four pricey transistors meant a little less than 20% in profits for Regency.
The Sony TR-63 hit shelves in 1957. It sported six transistors and sold for roughly $354 of today's dollars.
Smaller, more powerful, cheaper – with fatter profit margins, to boot.
By 1959, there were 6 million personal radios in America that brought in $1.3 billion (in 2020 terms) in profits for the three Japanese companies – Sony, Sharp, and Toshiba – that made them.
In 2020, every single iPhone 11 Apple makes sports 8.5 billion transistors, more than 171 million per square millimeter of chip. Estimates vary, but Apple may make 40% in profits on every unit sold.
You could easily argue the transistor belongs up there with the wheel, the nail, and the brick among the inventions that "changed everything." It has certainly generated incalculable wealth.
Today, the semiconductor industry is worth around $430 billion and counting.
And, as I'll show you in a second, transistors can still get smaller and more ubiquitous. And, just as importantly, they can still build fortunes as only technology can… Full Story
Why Your Next Big Profit Opportunity Is Companies Getting Smaller
Joseph Papa, the CEO of Bausch Health Cos. Inc., was hired in 2016 to help turn the pharmaceutical company around.
Instead, he is breaking it up. But he's not crazy.
He's caught on to the fact that bigger isn't always better.
You see, Bausch Health and its subsidiary, Bausch + Lomb eye care, are two great companies… but together, they aren't exactly chocolate and peanut butter.
Papa has realized that the only thing worse than no partnership at all is a bad partnership. So he's letting Bausch + Lomb become its own $3.1 billion business.
This means that both companies will be free to focus on their own business models, their own specialized products, and their own target markets.
It's a move that's going to create billions in new shareholder value.
And while I applaud the move, I think that there's an even better way to cash in on corporate spinoffs like this one.
That's because Joseph Papa's move is part of a massive trend that will be extremely profitable for investors… Full Story
Buy This "Post-COVID America" Money-Doubler at a Great Discount
The best minds in biotech are working round the clock to put a stop to the COVID-19 pandemic. The project includes over 135 vaccine candidates, and the profit potential here is massive.
This is literally about saving the world.
The thing is, though, vaccines are only one part of this project. There's another dimension, a "silent partner" in the project, that doesn't get quite so much heroic headline ink but is just as important.
You see, of all the vaccines coming down the pipeline, 31 are currently in human trials. There's a very good chance that one of them will be safe and powerful enough to begin mass distribution in early 2021.
But there are 328 million living Americans and 7.5 billion humans on planet earth. It will take time to vaccinate them all, and that's where our "silent partner" comes in.
It's blazing a trail towards the kind of better COVID-19 testing technology we will need to get things fully back to normal.
And not only that – it's on a solid track to double your money in just two years… Full Story
And not only that - it's on a solid track to double your money in just two years...
Forget the “Cashless Future” – the Cashless Now Is Where the Profit Is
Despite what most people think, the cashless “future” is already here.
And there’s a company with the vision to see this as a $2.7 trillion opportunity for the taking.
If anyone is going to deliver the convenient, cashless future we’ve been hearing about for decades, it’ll be these folks….